Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Want a daily digest of the top Nashville news?
Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.
Want a daily digest of the top Columbus news?
Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.
Want a daily digest of the top Dallas news?
Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
A medical researcher testing for antibodies against coronavirus. Photo: Karen Ducey/Getty Images
Some officials fear that the launch of antibody tests may become as problematic as the U.S.'s diagnostic testing effort, as fears rise about the tests' reliability and availability, the New York Times reports.
Why it matters: The tests show who has had the virus based on antibodies in their blood, even if they were asymptomatic. These people may have immunity from getting it again, although this is still unproven.
Between the lines: The antibody tests could be useful for gathering information about the true spread of the virus, and for potentially helping high-risk populations go back to work. But in both cases, that's only true if the tests are accurate and reliable.
- The Food and Drug Administration has taken a loose regulatory approach to the tests, allowing most manufacturers coming on the market to validate their own tests. These tests, some experts warn, may not be high-quality.
- Federal guidance regarding the tests is confusing, leading to some providers administering the tests who may not be authorized to do so, or misusing the tests to diagnose the coronavirus.
- The tests also have a high false positive rate, and may run into the same manufacturing problems plaguing diagnostic tests.
The bottom line: Antibody tests are an important tool in our coronavirus response, but they're a long ways from where they need to be.
Go deeper: How coronavirus antibody tests will help